Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele De Marco

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
RMD Open|November 2, 2021
Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to considerAlessia Alunno, Aurélie Najm, Xavier Mariette, et al.
BMC Musculoskeletal Disorders|July 20, 2017
The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomesGabriele De Marco, Philip Helliwell, Dennis McGonagle, et al.
Annals of the Rheumatic Diseases|February 16, 2021
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to considerAlessia Alunno, Aurélie Najm, Xavier Mariette, et al.
Reumatismo|April 28, 2006
[Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis]Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, et al.
Frontiers in Medicine|December 10, 2021
The Digital Way to Intercept Psoriatic ArthritisIvan Giovannini, Philipp Bosch, Christian Dejaco, et al.
RMD Open|February 12, 2021
Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to considerAurélie Najm, Alessia Alunno, Xavier Mariette, et al.
Clinical and Experimental Rheumatology|August 17, 2024
Risk factors for psoriatic arthritis development in psoriasis patients: myths, pitfalls, and pearlsYonatan Shneor Patt, Abdulla Watad, Ivan Giovannini, et al.
Journal of Clinical Medicine|July 2, 2021
Psoriatic Dactylitis: Current Perspectives and New Insights in Ultrasonography and Magnetic Resonance ImagingNicolò Girolimetto, Ivan Giovannini, Gloria Crepaldi, et al.
RMD Open|June 22, 2023
Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforceGabriele De Marco, Alen Zabotti, Xenofon Baraliakos, et al.
Rheumatology Advances in Practice|August 13, 2025
Similar rates of new psoriatic arthritis diagnoses in a dedicated psoriatic disease triage clinic, regardless of referral routeKatya Meridor, Stephanie R Harrison, Gabriele De Marco, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
RMD Open|November 2, 2021
Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to considerAlessia Alunno, Aurélie Najm, Xavier Mariette, et al.
BMC Musculoskeletal Disorders|July 20, 2017
The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomesGabriele De Marco, Philip Helliwell, Dennis McGonagle, et al.
Annals of the Rheumatic Diseases|February 16, 2021
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to considerAlessia Alunno, Aurélie Najm, Xavier Mariette, et al.
Reumatismo|April 28, 2006
[Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis]Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, et al.
Frontiers in Medicine|December 10, 2021
The Digital Way to Intercept Psoriatic ArthritisIvan Giovannini, Philipp Bosch, Christian Dejaco, et al.
RMD Open|February 12, 2021
Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to considerAurélie Najm, Alessia Alunno, Xavier Mariette, et al.
Clinical and Experimental Rheumatology|August 17, 2024
Risk factors for psoriatic arthritis development in psoriasis patients: myths, pitfalls, and pearlsYonatan Shneor Patt, Abdulla Watad, Ivan Giovannini, et al.
Journal of Clinical Medicine|July 2, 2021
Psoriatic Dactylitis: Current Perspectives and New Insights in Ultrasonography and Magnetic Resonance ImagingNicolò Girolimetto, Ivan Giovannini, Gloria Crepaldi, et al.
RMD Open|June 22, 2023
Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforceGabriele De Marco, Alen Zabotti, Xenofon Baraliakos, et al.
Rheumatology Advances in Practice|August 13, 2025
Similar rates of new psoriatic arthritis diagnoses in a dedicated psoriatic disease triage clinic, regardless of referral routeKatya Meridor, Stephanie R Harrison, Gabriele De Marco, et al.
Pageof 5